ABCG2 and neoplasm: Furthermore, the early upregulation of BCRP expression due to tumor opens a possibility to use this transporter as cancer biomarker; thus, establishing a rapid, reliable, and clinically available method for estimating the activity of xenobiotic transport may be indispensable for effective cancer therapy.